SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $579,553 | +1.1% | 4,781 | -4.5% | 0.27% | +2.3% |
| Q2 2023 | $573,173 | -46.1% | 5,005 | -35.1% | 0.26% | -69.7% |
| Q1 2023 | $1,063,083 | +6.4% | 7,713 | 0.0% | 0.87% | +46.0% |
| Q4 2022 | $999,451 | +12.9% | 7,713 | -3.7% | 0.59% | +17.4% |
| Q3 2022 | $885,000 | +23.3% | 8,009 | -16.4% | 0.50% | +16.6% |
| Q2 2022 | $718,000 | -18.8% | 9,581 | -15.3% | 0.43% | -23.0% |
| Q1 2022 | $884,000 | -8.5% | 11,310 | +99.6% | 0.56% | -8.9% |
| Q4 2020 | $966,000 | +134.5% | 5,667 | +120.5% | 0.62% | +80.9% |
| Q2 2020 | $412,000 | – | 2,570 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |